Market Research Logo

Global Antifungal Drugs Market Forecast 2019-2029

Price Length Publisher Published Date SKU
from $4,374 203 Pages Visiongain June, 2019 VSG16005593
Price from $4,374
Length 203 Pages
Publisher Visiongain
Published Date June, 2019
SKU VSG16005593
$4,874
$8,749
$4,374
$6,249
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093

Global Antifungal Drugs Market Forecast 2019-2029

The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 203-page report you will receive 85 tables and 101 figures– all unavailable elsewhere.

The 203-page report provides clear detailed insight into the antifungal drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Antifungal Drugs Market forecasts from 2019-2029
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Segment:
  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Indication:
  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Drugs:
  • Voriconazole
  • Posaconazole
  • Clotrimazole
  • Isavuconazole
  • Fluconazole
  • Caspofungin
  • Micagunfin
  • Amphotericin
  • Lamisil
  • Global Antifungal Drugs Market forecasts from 2019-2029 by regional and national market:
  • North America: The U.S., Canada
  • Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
  • Asia-Pacific: Japan, China, India, Rest of APAC
  • Latin America: Brazil, Mexico, Rest of Latin America
Each regional market is further segmented into Azoles, Echinocandins, Polyenes, Allylamines, Dermatophytosis, Aspergillosis, Candidiasis, Others
  • Profiles of the selected leading companies:
  • Abbott Laboratories
  • Bayer AG
  • Enzon Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Kramer Laboratories, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer
  • Sanofi S.A.
  • Antifungal Drugs R&D Pipeline
  • Key Questions Answered by this Report:
  • How is the Antifungal Drugs market evolving?
  • How will each Antifungal Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
  • How will the market shares for each Antifungal Drugs submarket develop from 2019 to 2029?
  • Will leading national Antifungal Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
  • Who are the leading players?
  • How will the industry evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the global antifungal drugs Market. You find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Global Antifungal Drugs Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Antifungal Drugs Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8. Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Antifungal Drugs
2.1. What are Antifungal Drugs?
2.2. The Evolution of Antifungal Drug Therapy?
2.2.1 History of antifungal therapy
2.2.2. Clinical Indications
2.3. Antifungal Drugs Segmentation
2.3.1 Azoles
2.3.1.1 Overview of Clinical Uses:
2.3.1.2. Indication Insights
2.3.2. Echinocandins
2.3.2.1 Echinocandins and Relevance in Biofilms
2.3.3 Polyenes
2.3.4. Allylamines
2.4. Common Invasive Fungal Diseases
2.5. Currently available antifungal drugs
2.6. Market Dynamics
2.6.1 Drivers
2.6.1.1. Increasing incidence of fungal infections
2.6.1.2. Increase in awareness
2.6.2. Restraint
2.6.2.1 Increasing resistance to antifungal drugs
3. Antifungal Drugs Market, 2019-2029
3.1 Global Antifungal Drugs: Market Overview
3.1.1 Segments within the Global Antifungal Drugs Market
3.2 The Global Antifungal Drugs Market in 2017 and 2018
3.3 Global Antifungal Drugs: Market Forecast 2019-2029
3.3.1 Market Sectors That Will Drive Antifungal Drugs Growth
3.3.2 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029
3.4 Global Antifungal Drugs Market by Indication: Sales Forecast 2019-2029
3.4.1 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029
4. Leading Drugs in the Antifungal Drugs Market 2019-2029
4.1 The Global Antifungal Drugs Market in 2017 and 2018
4.2 Azoles
4.2.1. Voriconazole (Vfend)
4.2.2 Voriconazole (Vfend): Sales Forecast 2019-2029
4.2.3 Posaconazole (Noxafil)
4.2.4 Posaconazole (Noxafil): Sales Forecast 2019-2029
4.2.5. Clotrimazole (Canesten)
4.2.6. Clotrimazole (Canesten): Sales Forecast 2019-2029
4.2.7. Isavuconazole (CRESEMBA)
4.2.8. Isavuconazole (CRESEMBA): Sales Forecast 2019-2029
4.2.9. Fluconazole (Diflucan)
4.2.10. Fluconazole (Diflucan): Sales Forecast 2019-2029
4.3 Echinocandins
4.3.1. Caspofungin (Cancidas)
4.3.2. Caspofungin (Cancidas): Sales Forecast 2019-2029
4.3.3. Micafungin (Mycamine/ Funguard)
4.3.4. Micafungin (Mycamine/ Funguard): Sales Forecast 2019-2029
4.4 Polyenes
4.4.1. AmBisome (Gilead Sciences)
4.4.2 AmBisome: Sales Forecast 2019-2029
4.5 Allylamines
4.5.1. Lamisil (terbinafine) - Novartis
4.5.1.1 Lamisil Patent Expiry
4.5.1.2 Lamisil Sales Affected by Novartis Manufacturing Problems
4.5.1.3. Lamisil: Sales Forecast 2019-2029
5. Leading National Markets 2019-2029
5.1. Geographical Breakdown of the World Antifungal Drugs Market
5.2 World Antifungal Drugs Market: Regional Forecast 2019-2029
5.2.1 How Will Regional Market Shares Change to 2029?
6. North America Antifungal Drugs Market 2019-2029
6.1. US Antifungal Drugs Market: Market Forecast 2019-2029
6.2. Canada Antifungal Drugs Market: Trends and Developments
7. Europe Antifungal Drugs Market 2019-2029
7.1 Europe Markets: Changing Market Shares by Country, 2019-2029
7.2 Germany
7.2.1 German Antifungal Drugs Market: Market Forecast 2019-2029
7.3. France Antifungal Drugs Market Forecast 2019-2029
7.4. U.K.
7.4.1. U.K. Antifungal Drugs Market Forecast 2019-2029
7.5 Italy
7.5.1 Italy Antifungal Drugs Market Forecast 2019-2029
7.6. Spain Antifungal Drugs Market Forecast 2019-2029
7.7. Rest of Europe Antifungal Drugs Market Forecast 2019-2029
8. Asia-Pacific Antifungal Drugs Market 2019-2029
8.1. Japan Antifungal Drugs Market: Trends and Developments
8.1.1 Japanese Antifungal Drugs Market Forecast 2019-2029
8.2 China
8.2.1 Chinese Antifungal Drugs Market Forecast 2019-2029
8.3. India
8.3.1 Indian Antifungal Drugs Market Forecast 2019-2029
8.4. Rest of Asia-Pacific Antifungal Drugs Market: Trends and Developments
9. Latin America Antifungal Drugs Market 2019-2029
9.1 Brazil: Focus on Domestic Drug Manufacturing
9.1.1 Brazil Antifungal Drugs Market Forecast 2019-2029
9.2. Mexico Antifungal Drugs Market: Trends and Developments
9.3. Rest of Latin America Antifungal Drugs Market: Trends and Developments
10. Middle East & Africa Antifungal Drugs Market 2019-2029
10.1. Saudi Arabia Antifungal Drugs Market Forecast 2019-2029
10.2. South Africa Antifungal Drugs Market Forecast 2019-2029
10.3. Rest of Middle East & Africa Antifungal Drugs Market Forecast 2019-2029
11. Leading Companies in the Antifungal Drugs Market, 2019
11.1 Novartis AG
11.1.1 Novartis: Antifungal Drugs Product Portfolio
11.1.2 Novartis AG: Financial Overview
11.1.3 Novartis AG: Recent Transactions Summary
11.2. Pfizer, Inc.
11.2.1 Pfizer, Inc.: Antifungal Drugs Portfolio
11.2.2 Pfizer, Inc.: Financial Overview
11.2.3 Pfizer, Inc.: Recent Developments
11.3. Sanofi S.A.
11.3.1 Sanofi S.A.: Antifungal Drugs Portfolio
11.3.2 Sanofi S.A.: Financial Overview
11.3.3 Sanofi S.A.: Recent Developments
11.4. GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc: Antifungal Drugs Portfolio
11.4.2 GlaxoSmithKline plc: Financial Overview
11.4.3 GlaxoSmithKline plc: Recent Transactions Summary
11.5. Bayer AG
11.5.1 Bayer AG: Antifungal Drugs Portfolio
11.5.2 Bayer AG: Financial Overview
11.5.3 Bayer AG: Recent Transactions Summary
11.6. Merck & Co., Inc.
11.6.1 Merck & Co., Inc.: Antifungal Drugs Portfolio
11.6.2 Merck & Co., Inc.: Financial Overview
11.6.3 Merck & Co., Inc.: Recent Transactions Summary
11.7. Abbott Laboratories
11.7.1 Abbott Laboratories: Antifungal Drugs Product Portfolio
11.7.2 Financial Overview
11.7.3 Recent Transactions Summary
11.8. Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc.: Antifungal Drugs Product Portfolio
11.8.2 Financial Overview
11.8.3 Recent Transactions Summary
11.9. Enzon Pharmaceuticals, Inc.
11.9.1 Enzon Pharmaceuticals, Inc.:Antifungal Drugs Product Portfolio
11.9.2 Financial Overview
11.10. Kramer Laboratories, Inc.
11.10.1 Kramer Laboratories, Inc.: Antifungal Drugs Product Portfolio
11.10.2 Recent Transactions Summary
12. Antifungal Drugs R&D Pipeline 2018
12.1. Antifungal drug development considerations
12.2. The antifungal pipeline
13. Conclusions
13.1 The World Antifungal Drugs Market in 2017 and 2018
13.1.1 Current Leading Antifungal Drugs Segments
13.1.2 Leading Regional Markets
13.2 World Antifungal Drugs Market Forecast 2019-2029
13.3 The Future of the Antifungal Drugs Market?
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Tables
Table 2.1 Classification of Anti-Fungal Agents
Table 2.1 Azoles as Antifungal Agents
Table 2.3 Toxicity OF Azoles
Table 2.4 Common Invasive Fungal Diseases
Table 3.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018
Table 3.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 3.3 Global Antifungal Drugs Market by Sector: CAGR (%), 2019-2023, 2023-2029, 2019-2029
Table 3.4 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
Table 3.5 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 3.6 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
Table 4.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018
Table 4.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.3 Global Azoles Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029
Table 4.4 Voriconazole (Vfend) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.5 Posaconazole (Noxafil) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.6 Clotrimazole (Canesten) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.7 Isavuconazole (CRESEMBA) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.8 Fluconazole (Diflucan) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.9 Global Echinocandins Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029
Table 4.10 Caspofungin (Cancidas) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.11 Micafungin (Mycamine/ Funguard) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.12 Global Polyenes Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029
Table 4.13 AmBisome Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 4.14 Global Allylamines Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029
Table 4.15 Lamisil Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 5.1 Global Antifungal Drugs Market by Region: Revenue ($m), 2017 and 2018
Table 5.2 Global Antifungal Drugs Market Forecast by Region: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 5.3 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
Table 5.4 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
Table 6.1 North America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 6.2 North America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 6.3 North America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 6.4 U.S. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 6.5 Canada Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 7.1 Europe Antifungal Drugs Market by Country/Sub-region: Revenue ($m) and Market Share (%), 2017
Table 7.2 Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 7.3 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 7.4 Europe Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 7.5 Europe Antifungal Drugs Market by Country/Sub-region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
Table 7.6 Germany Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
Table 7.7 France Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 7.8 U.K. Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 7.9 Italy Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
Table 7.10 Spain Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
Table 7.11 Rest of Europe Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
Table 8.1 Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 8.2 Asia-Pacific Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 8.3 Asia-Pacific Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
Table 8.4 Japan Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 8.5 China Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 8.6 India Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 8.7 Rest of Asia-Pacific Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 9.1 Latin America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 9.2 Latin America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 9.3 Latin America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 9.4 Brazil Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 9.5 Mexico Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 9.6 Rest of Latin America Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 10.1 Middle East and Africa Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
Table 10.2 Middle East & Africa Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 10.3 Middle East & Africa (MEA) Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
Table 10.4 Saudi Arabia Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
Table 10.5 South Africa Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
Table 10.6 Rest of MEA Antifungal Drugs Market Forecast; ($m, AGR%, CAGR%), 2019-2029
Table 11.1 Novartis AG: Overview
Table 11.2 Novartis AG: Revenue ($m), AGR (%), 2014-2018
Table 11.3 Pfizer, Inc.: Overview
Table 11.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
Table 11.5 Sanofi S.A.: Overview
Table 11.6 Sanofi S.A.: Revenue ($m), AGR (%), 2014-2018
Table 11.7 GlaxoSmithKline plc: Overview
Table 11.8 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2014-2018
Table 11.9 Bayer AG: Overview
Table 11.10 Bayer AG: Revenue ($m), AGR (%), 2014-2018
Table 11.11 Merck & Co., Inc.: Overview
Table 11.12 Merck & Co., Inc.: Revenue ($m), AGR (%), 2014-2018
Table 11.13 Abbott Laboratories: Overview
Table 11.14 Abbott Laboratories: Revenue ($m), AGR (%), 2014-2018
Table 11.15 Gilead Sciences, Inc.: Overview
Table 11.16 Gilead Sciences, Inc.: Revenue ($m), AGR (%), 2014-2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

Other tasks